3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Withdrawn
1
Unknown
1
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
4
Fallopian Tube Neoplasms
3
Stomach Neoplasms
2
Peritoneal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Peritoneal Cancer
1
Neoplasm Metastasis
1
Mesothelioma
1
Colorectal Neoplasms
1
Colorectal Cancer Metastatic
1
Interventions
Fluorouracil
80
Oxaliplatin
72
Leucovorin
66
Irinotecan
60
Capecitabine
58
Bevacizumab
57
Cetuximab
43
Folfox protocol
22
Drug Therapy
22
Neoadjuvant Therapy
19
HMPL-013
17
Colonoscopy
17
regorafenib
15
apatinib
11
Panitumumab
11
Chemotherapy, Adjuvant
11
trifluridine tipiracil drug combination
10
XELOX
10
Laparoscopy
10
IFL protocol
10
sintilimab
9
raltitrexed
9
Radiotherapy
9
Blood Specimen Collection
9
Surveys and Questionnaires
8
Surgical Procedures, Operative
8
tislelizumab
7
pembrolizumab
7
Endoscopic Mucosal Resection
7
Aspirin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Colorectal Neoplasms
×
Cytoreduction Surgical Procedures
×
Clear all
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled